About Acandis
Acandis is a company based in Pforzheim (Germany) founded in 2006. The company has 1 employees as of April 08, 2024. Acandis offers products and services including ACCERO Stent, DERIVO Embolisation Device, APERIO Hybrid Thrombectomy Device, and CREDO Stent. Acandis operates in a competitive market with competitors including Rapid Medical, CoAxia, Cerus Endovascular, Anaconda Biomed and Oxford Endovascular, among others.
- Headquarter Pforzheim, Germany
- Employees 1 as on 08 Apr, 2024
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Acandis India Private Limited
- Date of Incorporation 20 Dec, 2022
- Jurisdiction Mumbai, Maharashtra, India
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
-
Investors
Not available
-
Employee Count
1
as on Apr 08, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Acandis
Acandis offers a comprehensive portfolio of products and services, including ACCERO Stent, DERIVO Embolisation Device, APERIO Hybrid Thrombectomy Device, and CREDO Stent.
Stent for treating hemorrhagic strokes effectively.
Device for managing vascular aneurysms.
Tool for ischemic stroke intervention.
Stent designed for neurovascular applications.
People of Acandis
Unlock access to complete
Funding Insights of Acandis
Detailed funding history for Acandis
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Acandis
Investment portfolio details for Acandis
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Acandis
Detailed financials for Acandis
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Acandis Comparisons
Peer comparison for Acandis
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Acandis
Acandis operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Rapid Medical, CoAxia, Cerus Endovascular, Anaconda Biomed and Oxford Endovascular, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Neurovascular interventional devices including distal access catheters are developed.
|
|
| Locked | Locked | Locked |
Catheter-based treatment for cerebral ischemia
|
|
| Locked | Locked | Locked |
Interventional neuroradiology devices are developed for minimally invasive aneurysm treatment.
|
|
| Locked | Locked | Locked |
Medical devices for mechanical thromboectomy and clot removal are developed.
|
|
| Locked | Locked | Locked |
Metallic mesh devices for brain aneurysms are developed.
|
|
| Locked | Locked | Locked |
A hybrid polymer-metal stent for brain aneurysms is developed.
|
Detailed competitors of Acandis
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Acandis
Complete news archive for Acandis
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Acandis
Acandis was founded in 2006.
Acandis is headquartered in Pforzheim, Germany. It is registered at Pforzheim, Baden-wurttemberg, Germany.
Kirsi Schuessler is the current CEO of Acandis.
As of Apr 08, 2024, the latest employee count at Acandis is 1.
Acandis was established in 2006 in Pforzheim, Germany, within the medical devices sector. Focus is placed on developing treatments for hemorrhagic and ischemic strokes. Key products include the Acclino flex, a nitinol stent designed for aneurysm bridging with an asymmetric cell structure, and the Derivo, a flow diverter that lowers aneurysm flow velocity to promote thrombosis. Operations center on innovation in neurovascular interventions.
Acandis's top competitors include Rapid Medical, Fluid Biomed and Anaconda Biomed.
Acandis offers ACCERO Stent, DERIVO Embolisation Device, APERIO Hybrid Thrombectomy Device, and CREDO Stent.